iCAD Inc. (ICAD): Earnings growth forecast for next year
iCAD, Inc. (ICAD) utilizes a scalable SaaS model that enables the deployment of cloud-based diagnostic algorithms without capital expenditures. The business is shielded from geopolitical shocks due to the humanitarian status of medical AI technologies. B2B software sales and a partnership with Google Health are driving the stock's growth. The projected growth rate of net income per share demonstrates the model's market sensitivity, where 50.50 represents the latest metric reading.
Analytical breakdowns for iCAD (ICAD)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- book capitalization indicators:
- debt and liquidity data:
- earnings and valuation multiples information:
ICAD - Net Income|Future Profit iCAD, Inc.|ICAD - Business Payback Period|Forward P/E Multiple iCAD Inc.|ICAD - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple iCAD|ICAD - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) iCAD|ICAD - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth icadmed.com|ICAD - Earnings per share growth this year|Earnings growth forecast for next year iCAD, Inc.
Fundamental company valuation:iCAD, Inc., ICAD
To isolate the fundamental stability of iCAD, Inc. (ICAD) from market noise, a metric of the average expected earnings growth for the following year is utilized, measuring the expansion rate of net income per share. By analyzing the projected EPS growth rate, an investor assesses the capitalization potential, which in this instance is supported by the implementation of the ProFound AI platform and the update of software for predictive cancer diagnostics.
Competitor analysis
ONC (BeiGene Corp) - Earnings growth forecast for next year|Expected net earnings per share growth next year Halozyme Corp HALO|Earnings growth forecast for next year RVMD|Consensus forecast of earnings per share growth for next year ascentage.com|Earnings growth forecast for next year CGON (CG Oncology)|URGN - Expected earnings per share growth for next year|Bicara Bio - Earnings growth forecast for next year|PSNL - Earnings growth forecast for next year|ERAS: Earnings growth forecast for next year|Projected earnings per share growth rate for next year DCTH|Expected earnings per share growth for next year YMAB|AURA: Expected earnings per share trend next year|Earnings growth forecast for next year CADL|Consensus forecast of earnings per share growth for next year Accuray, Inc.|Net earnings per share growth forecast for next year SELLAS Life Sciences Group SLS|ACTU: Projected earnings per share growth rate for next year|Citius Oncology - Earnings growth forecast for next year|TuHURA Biosciences, Inc. (HURA) - Expected earnings per share growth for next year|TARA (Protara) - Expected earnings per share growth for next year|FATE - Consensus forecast of earnings per share growth for next year|WHWK (Aadi Bioscience, Inc.) - Earnings growth forecast for next year|TScan (TCRX) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year CSBR|Expected earnings per share growth for next year xbiotech.com XBIT|Earnings growth forecast for next year CVM (CEL-SCI)|Earnings growth forecast for next year OS Therapies, Inc. OSTX|Radiopharm Theranostics Limited - Earnings growth forecast for next year|ARTV (Artiva Biotherapeutics, Inc.) - Projected earnings per share growth rate for next year|ANL: Earnings growth forecast for next year|Expected earnings per share growth for next year Veru Inc|TPST (Tempest Tx) - Earnings growth forecast for next year|Earnings growth forecast for next year Xilio|Net earnings per share growth forecast for next year Renovaro Inc. (RENB)|muraloncology.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year KAPA (Kairos Pharma)|OKUR - Expected earnings per share growth for next year|CytoMed - Earnings growth forecast for next year|Expected net earnings per share growth next year Curis, Inc.|apollomicsinc.com (APLM) - Net earnings per share growth forecast for next year|tharimmune.com - Expected earnings per share trend next year|Expected earnings per share growth for next year ADVB|GNPX: Expected earnings per share trend next year|Earnings growth forecast for next year CLDI|Expected earnings per share growth for next year Sunshine Biopharma Inc. SBFM|Xenetic Biosciences, Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year salariuspharma.com SLRX|PPBT - Net earnings per share growth forecast for next year|Expected earnings per share trend next year AONC (American Oncology Network)|BGNE: Earnings growth forecast for next year|Expected net earnings per share growth next year Checkpoint Therapeutics Inc (CKPT)|ELEV (Elevation Oncology, Inc.) - Earnings growth forecast for next year|Ikena (IKNA) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year NTBL|Expected earnings per share growth for next year viracta.com VIRX|Earnings growth forecast for next year MOR (MorphoSys Corp)|Earnings growth forecast for next year NAYA Biosciences Corp NAYA|Ascentage Pharma Group - Earnings growth forecast for next year
